More topics

Limited coverage criteria – somatropin

Last updated on March 24, 2025

 

Return to Special Authority drug list

Generic (brand) name

Strength

Form
somatropin (Genotropin®) 5.3 mg, 12 mg / pen (GoQuick™); 0.6 mg, 0.8 mg, 1.0 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8 mg, 2.0 mg syringe (MiniQuick™)
somatropin (Humatrope®) 5 mg / vial; 6 mg, 12 mg, 24 mg cartridges
somatropin (Nutropin AQ®) 10 mg / cartridge (Pen®); 5mg, 10mg, 20mg cartridge (NuSpin®)
somatropin (Omnitrope®) 5 mg, 10 mg, 15 mg / cartridges cartridges
somatropin (Saizen®) 3.33 mg, 5 mg / vials; 8.8 mg / vial (click.easy®); 6 mg, 12 mg, 20 mg cartridges
somatropin (Norditropin® NordiFlex™, Norditropin® Flexpro™) 5 mg, 10 mg, 15 mg prefilled pen

Special Authority criteria

Approval period

For patients 20 years and younger, when a Special Authority request is submitted by:

  • Endocrinologist at the BC Children's Hospital for true growth hormone deficiency

OR 

  • Nephrologist for chronic renal insufficiency
 Up to the patient's 21st birthday                                                                                       

Practitioner exemptions

  • None

Special notes

  • PharmaCare does not cover somatropin for patients age 21 and older
  • PharmaCare does not cover somatropin for the treatment of children with Noonan syndrome, Prader-Willi syndrome, or Turner syndrome

Special Authority request form(s)